Regenxbio Plummets After Brain Tumor Found in Trial Participant
Regenxbio Inc. shares sank after US regulators placed a hold on the company’s gene therapy trials because a patient was found to have a brain tumor.
By Gerry Smith · Bloomberg Markets
Regenxbio Inc. shares sank after US regulators placed a hold on the company’s gene therapy trials because a patient was found to have a brain tumor.